1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

CDER Talks Switches, Monograph 'More Than Ever,' But Mum On Changes

 
• By Malcolm Spicer

Officials from FDA's drug center describe their work on the Nonprescription Safe Use Regulatory Expansion initiative and on the center's evaluation of potential solutions to the OTC drug monograph process logjam. A CDER attorneys says FDA" is working towards finalizing" an NSURE regulatory framework.

FDA assures the drug industry that improving its processes for making more ingredients available OTC is important, but the agency is not ready to say when changes will happen.

Officials from FDA's Center for Drug Evaluation and Research speaking at a Consumer Healthcare Products Association conference in Rockville, Md

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America